Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: John O'Neill who wrote (19004)	4/14/1998 6:02:00 PM
From: Andreas Helke	Read Replies (1) \| Respond to of 32384

I often wonder why the pharmas don't just buy the complete biotech industry. With a combined market cap of the industry being lower than the market cap of a single big pharma company that should be pretty easy. But of course we could expect serious upward price movement if the pharma industry would really try to pull that off. I hope that Ligand stays independent. That way Lignad has far more potential for long term share price appreciation. And it does not make that much sense to hold Ligand stock with the hope of a serious short time gain. Andreas